Status:
COMPLETED
Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Healthy
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to assess the concentration of besifloxacin compared to gatifloxacin and moxifloxacin in human conjunctival tissue, following a single drop of the drug instilled topically...
Eligibility Criteria
Inclusion
- Willing to avoid all disallowed medications for the appropriate washout periods.
- Have a best corrected visual acuity of 0.60 logMAR or better in each eye as measured using an ETDRS chart.
Exclusion
- Have a known allergy and/or sensitivity to the test articles or its components or any therapy associated with the trial.
- Monocular.
- Have previously participated in a conjunctival biopsy study.
- Be currently enrolled in an investigational drug or device study or have uses of an investigational drug or device within 30 days of entry into this study.
- have a condition or is in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT00905762
Start Date
March 1 2009
End Date
April 1 2009
Last Update
December 9 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bausch & Lomb Incorporated
Rochester, New York, United States, 14609